Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0610
0.00 (0.00%)
May 30, 2025, 4:00 PM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $95.04 thousand as of May 30, 2025. Its market cap has decreased by -95.73% in one year.
Market Cap
95.04K
Enterprise Value
13.53M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 95.04K, a decrease of -99.89%. That is a compound annual growth rate of -77.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 95.04K | -93.17% |
| Dec 31, 2024 | 1.39M | 27.08% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | 62.11M | -26.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Veradigm | 721.76M |
| Nika Pharmaceuticals | 667.04M |
| Tian'an Technology Group | 614.49M |
| Elite Pharmaceuticals | 575.83M |
| Glass House Brands | 459.97M |
| CytoDyn | 434.59M |
| Northwest Biotherapeutics | 388.39M |